Related Experiment Video

Updated: Jul 6, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease

Paloma Bermejo1, Sagrario Martín-Aragón, Juana Benedí

  • 1Departamento de Farmacología, Facultad de Farmacia, Universidad Complutense de Madrid, Avenida de la Complutense s/n, 28040 Madrid, Spain. bescos@farm.ucm.es

Immunology Letters
|March 28, 2008
PubMed

Insights

Inflammatory markers like Interleukin-6 (IL-6) and Interferon-alpha (IFN-alpha) may signal early Alzheimer's disease (AD) progression. These changes in mild cognitive impairment (MCI) patients suggest inflammation is an early factor in AD development.

Area of Science:

  • Neuroscience
  • Immunology
  • Gerontology

Background:

  • Alzheimer's disease (AD) pathophysiology involves multiple factors.
  • Peripheral markers can indicate biochemical changes in AD and mild cognitive impairment (MCI).
  • Inflammation is increasingly recognized as a contributor to neurodegenerative diseases.

Purpose of the Study:

  • To investigate peripheral inflammatory markers in elderly individuals with MCI, AD, and normal cognition.
  • To compare plasma cytokine levels and platelet cyclooxygenase-2 (COX-2) in these groups.

Main Methods:

  • Plasma levels of IL-6, TNF-alpha, and IFN-alpha were measured.
  • Platelet levels of COX-2 were quantified.
  • 34 MCI patients, 45 AD patients, and 28 controls were analyzed.

Main Results:

  • MCI and AD patients exhibited similar TNF-alpha and COX-2 levels.
  • Distinct patterns were observed for IL-6 and IFN-alpha between MCI and AD.
  • Elevated IL-6 was found in AD, while increased IFN-alpha was specific to MCI, potentially linked to depression.

Conclusions:

  • Peripheral inflammatory responses may precede or accompany early stages of AD.
  • Changes in circulating markers like IL-6 and IFN-alpha could indicate disease progression from MCI to AD.
  • Inflammation is a potential early factor in Alzheimer's disease development.

More Related Videos

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles04:22

Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles

Published on: May 20, 2024

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...